Both warfarin and direct oral anticoagulants are susceptible to drug-drug interactions (DDIs). ... Nehmiz G, Reilly P. Oral bioavailability of dabigatran etexilate (Pradaxa(®)) after co-medication ...

Bristol-Myers makes an $11 billion deal with BioNTech to join the new cancer-treatment game, nearly double the size of Pfizer’s deal announced two weeks earlier.

Home Music Legal Sean “Diddy” Combs Used Ex-Girlfriend “Jane” As A Drug Mule, Last “Freak-Off” Occurred Just Before Arrest, Sex-Trafficking Trial Hears ...

Medicare is negotiating the prices of 15 drugs, including Novo Nordisk's Ozempic.The government has until Nov. 30 to announce the agreed-upon Medicare prices. The lower prices would go into effect ...

The drugs are already being investigated as treatments for certain muscle- or bone-related conditions, but Regeneron reasoned that they could also be used to proactively prevent muscle loss while ...

BCSO said an alleged drug-related shooting led to the discovery of narcotics and weapons at a far west-side San Antonio home and the arrest of a father and son.

GLP-1 drugs like Ozempic and Wegovy might help you ditch the food baby, but they could also affect your ability to make a real one. Ayla Barmmer, a registered dietitian and reproductive health ...

DENPASAR, Indonesia (AP) — Three British nationals accused of smuggling nearly a kilogram (over two pounds) of cocaine into Indonesia were charged Tuesday in a court on the tourist island of Bali.

Trump's executive order on drug prices gives no information on actual price targets and it doesn't disclose a plan for how to implement a most favored nation model.

In December, the U.S. Food and Drug Administration (FDA) approved a new treatment for people with insomnia, Dayvigo (lemborexant). The drug will be available in 5 or 10 milligram (mg) doses ...

In 2020, beneficiaries’ access to drugs in unprotected classes was limited through coverage exclusions, prior authorization requirements, or step therapy protocols on an average of 44.4 percent ...

Between 1995 and 2021 private money spent on Alzheimer’s research came to $42.5bn, but more than 140 trials failed to yield a single drug capable of slowing the disease. Yet the tide may be turning.